Does RISEDRONATE Cause Pulmonary fibrosis? 260 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 260 reports of Pulmonary fibrosis have been filed in association with RISEDRONATE (Risedronate Sodium). This represents 3.8% of all adverse event reports for RISEDRONATE.
260
Reports of Pulmonary fibrosis with RISEDRONATE
3.8%
of all RISEDRONATE reports
9
Deaths
218
Hospitalizations
How Dangerous Is Pulmonary fibrosis From RISEDRONATE?
Of the 260 reports, 9 (3.5%) resulted in death, 218 (83.8%) required hospitalization, and 7 (2.7%) were considered life-threatening.
Is Pulmonary fibrosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISEDRONATE. However, 260 reports have been filed with the FAERS database.
What Other Side Effects Does RISEDRONATE Cause?
Drug hypersensitivity (1,124)
Asthma (1,087)
Pain (973)
Vomiting (971)
Drug ineffective (919)
Dyspnoea (898)
Pneumonia (807)
Wheezing (772)
Oedema (708)
Malaise (668)
What Other Drugs Cause Pulmonary fibrosis?
METHOTREXATE (2,912)
ADALIMUMAB (2,277)
RITUXIMAB (2,192)
ETANERCEPT (1,926)
TOCILIZUMAB (1,886)
ABATACEPT (1,828)
HYDROXYCHLOROQUINE (1,740)
LEFLUNOMIDE (1,731)
PREDNISONE (1,692)
INFLIXIMAB (1,595)
Which RISEDRONATE Alternatives Have Lower Pulmonary fibrosis Risk?
RISEDRONATE vs RISEDRONIC ACID
RISEDRONATE vs RISPERDAL
RISEDRONATE vs RISPERDAL CONSTA
RISEDRONATE vs RISPERIDONE
RISEDRONATE vs RITALIN